Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 6, Pages 687–699
http://dx.doi.org/10.1155/2013/484959
Review Article

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis

Section of Clinical Neurology, Department of Neurological and Movement Sciences, University of Verona, Neurology Unit, Borgo Roma, Azienda Ospedaliera Universitaria Integrata Verona, Piazzale Ludovico Antonio Scuro 9, 37134 Verona, Italy

Received 30 June 2013; Revised 12 September 2013; Accepted 9 October 2013

Academic Editor: Ralf Lichtinghagen

Copyright © 2013 Alberto Gajofatto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [27 citations]

The following is the list of published articles that have cited the current article.

  • Fozia Mir, Donald Lee, Hetal Ray, and Saud A. Sadiq, “CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis,” Neurology: Neuroimmunology and NeuroInflammation, vol. 1, no. 2, 2014. View at Publisher · View at Google Scholar
  • Itay Raphael, Johanna Webb, Olaf Stuve, William Haskins, and Thomas Forsthuber, “Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future,” Expert Review of Clinical Immunology, pp. 1–23, 2014. View at Publisher · View at Google Scholar
  • Massimiliano Calabrese, Alberto Gajofatto, and Maria Donata Benedetti, “Therapeutic strategies for relapsing–remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy,” Expert Review of Neurotherapeutics, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Matteo Caffini, Niels Bergsland, Marcella Lagana, Eleonora Tavazzi, Paola Tortorella, Marco Rovaris, Giuseppe Baselli, Matteo Caffini, Niels Bergsland, Marcella Lagana, Eleonora Tavazzi, Paola Tortorella, Marco Rovaris, and Giuseppe Baselli, “Surface-based reconstruction and diffusion MRI in the assessment of gray and white matter damage in multiple sclerosis,” Medical Imaging 2014: Image Processing, vol. 9034, 2014. View at Publisher · View at Google Scholar
  • Vacaras Vitalie, Zoltan Zsigmond, Maris Emilia, Kinga Andrea, and Buzoianu Anca Dana, “Multiple sclerosis with stroke-like symptoms: a diagnostic challenge. Case report,” Orvosi Hetilap, vol. 156, no. 37, pp. 1514–1518, 2015. View at Publisher · View at Google Scholar
  • B.C. Kieseier, “Multiple sclerosis - a dynamic field with a need for excellent education,” European Journal of Neurology, vol. 22, pp. 1–2, 2015. View at Publisher · View at Google Scholar
  • Li Zhou, and Yongping Fan, “Randomized trial of erhuangfang for relapsing multiple sclerosis,” Neurological Research, vol. 37, no. 7, pp. 633–637, 2015. View at Publisher · View at Google Scholar
  • Brit Fitzner, Michael Hecker, and Uwe Klaus Zettl, “Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients,” Autoimmunity Reviews, 2015. View at Publisher · View at Google Scholar
  • Sasan Andalib, Mahnaz Talebi, Ebrahim Sakhinia, Mehdi Farhoudi, Homayoun Sadeghi-Bazargani, and Albert Gjedde, “Lack of association between mitochondrial DNA G15257A and G15812A variations and Multiple Sclerosis,” Journal of the Neurological Sciences, 2015. View at Publisher · View at Google Scholar
  • Sasan Andalib, Mahnaz Talebi, Ebrahim Sakhinia, Mehdi Farhoudi, Homayoun Sadeghi-Bazargani, and Albert Gjedde, “Mitochondrial DNA T4216C and A4917G variations in Multiple Sclerosis,” Journal of the Neurological Sciences, 2015. View at Publisher · View at Google Scholar
  • T. Uher, D. Horakova, T. Kalincik, N. Bergsland, M. Tyblova, D. P. Ramasamy, Z. Seidl, M. Vaneckova, J. Krasensky, E. Havrdova, and R. Zivadinov, “Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a,” European Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • Laura Airas, Eero Rissanen, and Juha O. Rinne, “Imaging neuroinflammation in multiple sclerosis using TSPO-PET,” Clinical and Translational Imaging, 2015. View at Publisher · View at Google Scholar
  • Sara Ribes García, Bonaventura Casanova Estruch, Fernando Gómez-Pajares, Carmen Albelda Puig, and José Luis García Herrera, “Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade,” European Neurology, vol. 75, no. 5-6, pp. 274–281, 2016. View at Publisher · View at Google Scholar
  • Sasan Andalib, Mohammadreza Emamhadi, Shahrokh Yousefzadeh-Chabok, Arsalan Salari, Abdolhosein Emami Sigaroudi, and Manouchehr Seyedi Vafaee, “MtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis,” Acta Neurologica Belgica, 2016. View at Publisher · View at Google Scholar
  • Emanuele D’Amico, Aurora Zanghì, and Francesco Patti, “Personalized therapy in multiple sclerosis: state of art and future perspectives,” Expert Review of Precision Medicine and Drug Development, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Alberto Gajofatto, Marco Turatti, and Maria Donata Benedetti, “Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives,” Expert Review of Neurotherapeutics, vol. 17, no. 4, pp. 393–406, 2016. View at Publisher · View at Google Scholar
  • Macmillan, Tam, Zhao, Vavasour, Li, Oger, Freedman, Kolind, and Traboulsee, “Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years,” Multiple Sclerosis, vol. 22, no. 1, pp. 112–116, 2016. View at Publisher · View at Google Scholar
  • Yi Zou, Jiang Li, Yiyuan Cui, Peiren Tang, Lianghui Du, Tunan Chen, Kun Meng, Qiao Liu, Hua Feng, Jianheng Zhao, Mina Chen, and Li-Guo Zhu, “Terahertz Spectroscopic Diagnosis of Myelin Deficit Brain in Mice and Rhesus Monkey with Chemometric Techniques,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Ethel Ciampi, Deborah Pareto, Jaume Sastre-Garriga, Angela Vidal-Jordana, Carmen Tur, Jordi Río, Mar Tintoré, Cristina Auger, Alex Rovira, and Xavier Montalban, “Grey matter atrophy is associated with disability increase in natalizumab-treated patients,” Multiple Sclerosis Journal, vol. 23, no. 4, pp. 556–566, 2017. View at Publisher · View at Google Scholar
  • Anne-Claire Dupont, Bérenger Largeau, Maria Santiago Ribeiro, Denis Guilloteau, Claire Tronel, and Nicolas Arlicot, “Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases,” International Journal of Molecular Sciences, vol. 18, no. 4, pp. 785, 2017. View at Publisher · View at Google Scholar
  • S. Andalib, M. Talebi, E. Sakhinia, M. Farhoudi, H. Sadeghi-Bazargani, M.R. Emamhadi, N. Masoodian, M. Balaghi-Inalou, M.S. Vafaee, and A. Gjedde, “Mitochondrial DNA G13708A variation and multiple sclerosis: Is there an association?,” Revue Neurologique, vol. 173, no. 3, pp. 164–168, 2017. View at Publisher · View at Google Scholar
  • Jan Lycke, and Henrik Zetterberg, “The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis,” Expert Review of Clinical Immunology, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • G. Fenu, L. Lorefice, V. Sechi, L. Loi, F. Contu, F. Cabras, G. Coghe, J. Frau, M.A Secci, C Melis, L. Schirru, G. Costa, V. Melas, M. Arru, M.A. Barracciu, M.G. Marrosu, and E. Cocco, “Brain Volume in Early MS patients with and without IgG Oligoclonal Bands in CSF,” Multiple Sclerosis and Related Disorders, 2017. View at Publisher · View at Google Scholar
  • Sasan Andalib, Mahnaz Talebi, Ebrahim Sakhinia, Mehdi Farhoudi, Homayoun Sadeghi-Bazargani, Nooshin Masoudian, Tanja M. Michel, Manouchehr Seyedi Vafaee, and Albert Gjedde, “Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis,” Multiple Sclerosis and Related Disorders, 2018. View at Publisher · View at Google Scholar
  • Aung Zaw Zaw Phyo, Thibaut Demaneuf, Alysha M. De Livera, George A. Jelinek, Chelsea R. Brown, Claudia H. Marck, Sandra L. Neate, Keryn L. Taylor, Taylor Mills, Emily O’Kearney, Amalia Karahalios, and Tracey J. Weiland, “The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis,” Frontiers in Neurology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Adriano Luís Soares De Souza, Stefan Rudin, Rui Chang, Keith Mitchell, Timothy Crandall, Shuning Huang, Ji-Kyung Choi, Shinji L. Okitsu, Danielle L. Graham, Blake Tomkinson, and Tammy Dellovade, “ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs,” Neurology and Therapy, 2018. View at Publisher · View at Google Scholar
  • Renxin Chu, Gloria Kim, Shahamat Tauhid, Fariha Khalid, Brian C. Healy, and Rohit Bakshi, “Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines,” Plos One, vol. 13, no. 11, pp. e0206939, 2018. View at Publisher · View at Google Scholar